These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11369170)

  • 21. Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause.
    Griffin B; Farish E; Walsh D; Barnes J; Caslake M; Shepherd J; Hart D
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):463-8. PubMed ID: 8287573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoprotein E phenotype determines serum cholesterol in infants during both high-cholesterol breast feeding and low-cholesterol formula feeding.
    Kallio MJ; Salmenperä L; Siimes MA; Perheentupa J; Gylling H; Miettinen TA
    J Lipid Res; 1997 Apr; 38(4):759-64. PubMed ID: 9144090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins.
    Ishibashi S; Herz J; Maeda N; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4431-5. PubMed ID: 8183926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidized LDL autoantibodies are related to apolipoprotein E phenotype, independently of postprandial change in plasma triglycerides and LDL size, among patients with angiographically verified coronary artery disease and healthy controls.
    Metso S; Nikkilä M; Laippala P; Jaakkola O; Solakivi T; Lehtimäki T
    J Biomed Sci; 2003; 10(3):345-51. PubMed ID: 12711862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a).
    de Knijff P; Kaptein A; Boomsma D; Princen HM; Frants RR; Havekes LM
    Atherosclerosis; 1991 Oct; 90(2-3):169-74. PubMed ID: 1836947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E polymorphism in Vietnamese children and its relationship to plasma lipid and lipoprotein levels.
    Nghiem NT; Ta TT; Ohmori R; Kuroki M; Nguyen VC; Nguyen TK; Kawakami M; Kondo K
    Metabolism; 2004 Dec; 53(12):1517-21. PubMed ID: 15562392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study.
    Lehtimäki T; Moilanen T; Viikari J; Akerblom HK; Ehnholm C; Rönnemaa T; Marniemi J; Dahlen G; Nikkari T
    J Lipid Res; 1990 Mar; 31(3):487-95. PubMed ID: 2341810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3.
    Kobayashi T; Homma Y
    J Clin Pharmacol; 2001 Oct; 41(10):1055-8. PubMed ID: 11583472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse.
    Woollett LA; Osono Y; Herz J; Dietschy JM
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12500-4. PubMed ID: 8618929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins.
    Gómez-Coronado D; Alvarez JJ; Entrala A; Olmos JM; Herrera E; Lasunción MA
    Atherosclerosis; 1999 Nov; 147(1):167-76. PubMed ID: 10525138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E phenotypes and plasma lipids in diabetic children and adolescents.
    Salo MK; Rantanen R; Huupponen T; Lehtimäki T; Jokela H
    Eur J Pediatr; 1993 Jul; 152(7):564-8. PubMed ID: 8354314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human hepatic low-density lipoprotein receptors: associations of receptor activities in vitro with plasma lipid and apolipoprotein concentrations in vivo.
    Nanjee MN; Miller NE
    Biochim Biophys Acta; 1989 Apr; 1002(2):245-55. PubMed ID: 2495023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
    Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
    Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells.
    Mistry P; Miller NE; Laker M; Hazzard WR; Lewis B
    J Clin Invest; 1981 Feb; 67(2):493-502. PubMed ID: 6257763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Ozawa H; Sakane H; Nakamura H
    Atherosclerosis; 1997 Mar; 129(2):241-8. PubMed ID: 9105567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice.
    Auger A; Truong TQ; Rhainds D; Lapointe J; Letarte F; Brissette L
    Eur J Biochem; 2001 Apr; 268(8):2322-30. PubMed ID: 11298750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of unopposed conjugated equine estrogen on lipoprotein composition and apolipoprotein-E distribution.
    Muesing RA; Miller VT; LaRosa JC; Stoy DB; Phillips EA
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1250-4. PubMed ID: 1430085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students.
    Lehtimäki T; Moilanen T; Solakivi T; Laippala P; Ehnholm C
    Ann Med; 1992 Feb; 24(1):61-6. PubMed ID: 1575961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.